Subscribe Free
in Maintenance

Dnata awarded UK MHRA certification for Good Distribution Practice

Posted 19 April 2018 · Add Comment

Global air services provider and UK’s leading ground handler, Dnata, has been awarded certification for Good Distribution Practice (GDP) by the UK Medicines and Healthcare Products Regulatory Agency (UK MHRA).

 

The UK MHRA granted Dnata full Wholesaler Dealer Authorisation (WDA) after Dnata completed the organisation’s Good Distribution Programme, while simultaneously investing into cutting-edge pharma handling technology at several of its facilities.

Dnata’s investment includes a sophisticated 24-hour warehouse monitoring system that has the ability to conduct temperature mapping and advise Dnata operators ahead of any deviation in temperature. This, in, turn enables pre-planning, quick response to adapt to adverse weather conditions and assessment of potential transport routes for pharma products.

Temperature mapping is also routinely conducted within Dnata’s facilities in the summer and winter to gauge average temperatures.

This leading-edge technology recently paid dividends when the cold front struck in early March and temperatures across the UK plummeted. Dnata was able to prepare for the severe temperature onslaught, and ensure that all pharmaceuticals handled followed the optimum route, at temperatures that limited the risk of spoilage.

In addition, the company has installed automated handling systems that can store pharmaceuticals at variable temperature ranges.

In order to achieve certification, Dnata was required to either review or make enhancements to its quality systems, operations documentation and facilities management practices – a 12 to 24-month process that it completed in just six months.

“We have invested in pharma-handling facilities across the UK in response to customer demand and in recognition of the growing importance of pharma cold-chain logistics,” said Dnata UK CEO Gary Morgan. 

“With world-class technology already in place at our facilities, the next logical step was to ensure standards compliance and achieve UK MHRA certification.  These initiatives not only demonstrate our ongoing focus on safety and quality, but also reinforce our commitment to our airline customers who operate in the fast-growing pharmaceutical transportation sector. ”

 

* required field

Post a comment

Other Stories
Advertisement
Latest News

Emirates takes off to Mexico City

Emirates has taken off to Mexico City, marking the airline's first passenger flight to Mexico.

Gulf Air expands international sales with APG

Gulf Air has signed up with APG to benefit from their latest ticketing solution APG IET being a worldwide solution for airlines wishing to develop their global sales by interlining.

Etihad Airways becomes first airline to raise funds tied to UN sustainable development

Etihad Airways has become the first airline to secure funding for a project based on its compatibility with the Sustainable Development Goals of the United Nations.

Emirates Cabin Crew recognised as world’s best at World Travel Awards Grand Final

Emirates cabin crew has been named World's Leading Cabin Crew 2019 at the World Travel Awards (WTA) Grand Final Gala Ceremony.

CAE and Emirates extend partnership on Boeing 777X training suites

CAE and Emirates have announced the sale of two Boeing 777X full-flight simulators and associated training suites of the CAE XR Series models. The carrier also has options for four additional training suites.

Emirates to expand in Mexico via enhanced agreement with Interjet Airlines

Emirates and Interjet Airlines, one of the fastest growing airlines in North America, have announced an enhanced interline agreement, which is set to open new routes and destinations for passengers travelling between Mexico, the Gulf

AVMENA20 SK1309100620
See us at
Sofex BT2611020420SaudiAirshow21SK2011180221AVAFA20BT2607050320AVMENA20 BT1309100620